Publikasi Scopus FKUI 2021 per tanggal 31 Juli 2021 (507 artikel)

Yunihastuti E., Lestari Agusin R., Sari V., Jhariah Hidayah A., Wulunggono W., Pramukti H., Shinta M., Shatri H., Harjono Karjadi T.
57221273925;57223400304;57223400647;57223397657;57211629741;57223395589;57223397294;28767986500;57223406089;
Prevalence and associated factors of depressive symptoms among people living with HIV on antiretroviral therapy in Jakarta, Indonesia
2021
Tropical Medicine and International Health
Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; HIV Integrated Unit RSUPN Dr Cipto Mangunkusumo Hospital, Jakarta, Indonesia
Yunihastuti, E., Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia, HIV Integrated Unit RSUPN Dr Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Lestari Agusin, R., Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Sari, V., Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Jhariah Hidayah, A., HIV Integrated Unit RSUPN Dr Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Wulunggono, W., Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Pramukti, H., Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Shinta, M., HIV Integrated Unit RSUPN Dr Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Shatri, H., Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Harjono Karjadi, T., Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia, HIV Integrated Unit RSUPN Dr Cipto Mangunkusumo Hospital, Jakarta, Indonesia
Objective: We aimed to investigate the prevalence of depressive symptoms among people living with HIV (PLHIV) on antiretroviral therapy (ART) in a large HIV treatment facility in Jakarta, Indonesia, and to assess associated factors. Methods: The Indonesian version of Beck Depression Inventory-II was used to assess depressive symptoms of 346 participants visiting the HIV Integrated Clinic Cipto Mangunkusumo hospital between June and November 2018. Results: Depressive symptoms (BDI-II score ≥14) were exhibited by 50.9% of participants, with prevalences of mild, moderate and severe depression of 30.4%, 15.6% and 4.9%, respectively. Poisson regression with robust variance analysis indicated that having lower income (aPR = 1.38, 95% CI 1.12–1.63), duration of ART for 1–5 years (aPR = 1.25, 95% CI 1.01–1.54) and same-sex partnership (aPR = 1.27, 95% CI 1.02–1.58) were positively associated with depressive symptoms. Age, sex and history of using intravenous drugs, and ART-based regimen were not associated with depressive symptoms. Conclusions: Depressive symptoms were common among our population despite long-term ART use and were associated with having low-income, ART for 1–5 years and same-sex partnership. © 2021 John Wiley & Sons Ltd
antiretroviral therapy; depression; depressive symptoms; human immunodeficiency virus
Blackwell Publishing Ltd
13602276
33930230
Article
Q1
1056
4040